Prone Breast Radiotherapy Treatment Planning Observational Study
NCT02237469 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 280
Last updated 2022-12-21
Summary
The study purpose is to evaluate whether or not clinical characteristics of women with breast cancer can predict which position for radiation treatment, prone or supine, will be associated with a dosimetry gain. Dosimetry gain in this study means the lowest radiation dose to non-target organs (heart, lungs, contralateral breast), while giving the prescribed dose to tumor bed and ipsilateral breast.
Conditions
- Breast Cancer Female
Interventions
- RADIATION
-
Prone and supine simulation
Treatment planning in the two positions.
Sponsors & Collaborators
-
Varian Medical Systems
collaborator INDUSTRY -
Vincent Vinh-Hung
lead OTHER
Principal Investigators
-
Vincent Vinh-Hung, MD, PhD · University of Genova
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-09-30
- Primary Completion
- 2013-04-30
- Completion
- 2023-12-31
Countries
- Switzerland
Study Locations
More Related Trials
-
Prone Whole-Breast RadiationTherapy Versus Supine Whole-Breast Radiation Therapy Imaging
NCT03037723 ·Status: COMPLETED ·Phase: NA
-
Feasibility Study of Breast MRI in Decubitus Position
NCT02865239 ·Status: COMPLETED ·Phase: NA
-
The Radiation Metabolic Signature of Patient Undergoing Radiotherapy. A Pilot Study
NCT01975558 ·Status: COMPLETED
-
MRI-guided Single Dose Preoperative Radiotherapy in Low-risk Breast Cancer
NCT03863301 ·Status: WITHDRAWN ·Phase: PHASE2
-
Single Dose Ablative Radiation Treatment for Early-Stage Breast Cancer
NCT02316561 ·Status: COMPLETED ·Phase: NA
-
Preoperative Partial Breast Irradiation in Early-Stage Breast Cancer
NCT06677944 ·Status: RECRUITING ·Phase: PHASE2
-
Association of Adjuvant Radiotherapy of Non-metastatic Breast Carcinoma With Immunomodulation and Circulating Tumor Cell Phenotype in Relation to Patient Age.
NCT04902937 ·Status: RECRUITING
-
Monitoring and Predicting Breast Cancer Neoadjuvant Chemotherapy Response Using Diffuse Optical Spectroscopic Imaging
NCT01257932 ·Status: WITHDRAWN
-
Prospective Comparative Study of Hypofractionated Adjuvant Radiotherapy in 2 Virsus 3 Weeks in Breast Cancer
NCT07344597 ·Status: NOT_YET_RECRUITING
-
Monitoring Neoadjuvant Chemotherapy Response in Breast Cancer Patients Using Diffuse Optical Spectroscopic Imaging
NCT02510456 ·Status: COMPLETED
-
SBRT for Breast Cancer Oligometastases
NCT04424732 ·Status: RECRUITING ·Phase: NA
-
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
NCT01007890 ·Status: TERMINATED
-
The Prone to Supine Breast MRI Trial
NCT03573804 ·Status: COMPLETED ·Phase: NA
-
NearWave Optical Molecular Monitoring
NCT06744465 ·Status: RECRUITING ·Phase: NA
-
PET in Breast Cancer Receiving Neoadjuvant Chemotherapy
NCT01396655 ·Status: COMPLETED ·Phase: PHASE2
-
Radiotherapy After Primary Chemotherapy for Breastcancer
NCT01279304 ·Status: COMPLETED
-
Radiotherapy With Extreme Hypofractionation in Patients With Breast Cancer in Brazil: a Retrospective Cohort Study
NCT05776147 ·Status: RECRUITING
-
Prospective Validation of 3D Dose Metrics as Selection Criteria for Adaptive Radiotherapy in Breast Cancer Patients
NCT03385031 ·Status: COMPLETED
-
4D CT Scan Versus 3D CT Scan Concerning Cardiac Dosimetry Assesment for Left Sided Breast Cancers Radiotherapy
NCT05726604 ·Status: UNKNOWN ·Phase: NA
-
Improving the Approach to and Management of the Older Metastatic Breast Cancer Patient
NCT03007641 ·Status: COMPLETED ·Phase: NA
-
The Use of Deep Inspiration Breath Hold and Prone Irradiation to Decrease Cardiac Radiation Exposure
NCT03375892 ·Status: COMPLETED ·Phase: NA
-
Breast VCEUS to Evaluate Early Response to Neoadjuvant Chemotherapy
NCT01817374 ·Status: TERMINATED ·Phase: NA
-
Regional Lymph Node Irradiation for High-risk pN0 Breast Cancer
NCT05976412 ·Status: RECRUITING ·Phase: NA
-
Adjuvant Hypofractionated Intensity-Modulated Radiation Therapy With Incorporated Boost in Treating Patients With Early-Stage Breast Cancer
NCT00084539 ·Status: COMPLETED ·Phase: PHASE2
-
Quantitative Evaluation of the Breast's Morphological Variations During Radiotherapy: MorphoBreast3D
NCT03801850 ·Status: COMPLETED ·Phase: NA